ASH 2024: HARMONY Alliance activities at the 66th Annual Meeting of the American Society of Hematology

HARMONY Alliance experts will participate and present in different forums in the framework of the 66th Annual Meeting of the American Society of Hematology.


Saturday 7th

  • ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

This 90-minute special-interest session will focus on the ASH Research Collaborative’s Multiple Myeloma Program’s efforts to accelerate research and collaborative clinical care in hematologic malignancies. Three topics will describe the ASH Research Collaborative’s approach to aggregating and visualizing real-world data (RWD) in multiple myeloma in a US-based, multi-site network; a proof-of-concept study with a hybrid decentralized workflow that was conducted in the ASH RC Myeloma Network this year; and new directions for RWD analysis in hematologic malignancies, including the use of artificial intelligence. A panel will then highlight work that is being done by the European HARMONY Alliance and other real-world data registries.

  • Poster presentation: Development and Validation of Novel Machine Learning-Based Risk Scores for Multiple Myeloma: Insights from the Harmony Alliance Big Data Platform by Adrian Mosquera

Sunday 8th 

  • HARMONY Alliance Session at ELN Breakfast Meeting 
    • Time: 6:00 a.m. – 10:00 a.m.
    • Place: Liberty Station Conference Center

Link to the full program of the HARMONY Alliance Session


Monday 9th

HARMONY Alliance collaborators will be presenting scientific results in two oral presentations.

  • Oral presentation: Early Relapse in Patients with Newly-Diagnosed Multiple Myeloma: A European Myeloma Network/Harmony Alliance Analysis Including 10843 Patients by Elias K. Mai, Heidelberg University Hospital,  Germany
    • Time and Location:
      Monday, December 9, 2024: 2:45 PM-4:15 PM
      Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
    • Session: 653. Multiple Myeloma: Clinical and Epidemiological: Exploring T Cell Redirecting Therapies, Mutation Profiles and Early Relapse
    • Link to the abstract: https://ash.confex.com/ash/2024/webprogram/Paper193310.html
  • Oral presentation: The Prognostic Impact of Myelodysplasia-Related Gene Mutations in Acute Myeloid Leukemia with FLT3-ITD Mutations by Rabea Mecklenbrauck, Hannover Medical School, Germany
    • Time and Location:
      Monday, December 9, 2024: 2:45 PM-4:15PM
      Grand Hall C (Manchester Grand Hyatt San Diego)
    • Session: 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Genetic Markers and Outcomes in AML
      Hematology Disease Topics & Pathways
    • Link to the abstract: https://ash.confex.com/ash/2024/webprogram/Paper202362.html

Link to the annual meeting website >

Share this post

Spain

  • PETHEMA – Programa Español de Tratamientos en Hematología
  • Jose Carreras Leukemia Research Institute
  • Spanish CETLAM Cooperative Group
  • Hospital 12 de Octubre – i+12 Instituto de Investigación
  • Hospital Universitario La Fe
  • Fundació Institut Mar D´Investigacions Mèdiques
  • Complejo Asistencial Universitario de Burgos
  • Ramon y Cajal University Hospital
  • Infanta Leonor Hospital
  • Costa del Sol Hospital
  • Hospital General Universitario Valencia
  • Catalan Registry of CML
  • Hospital Universitario de Gran Canaria Doctor Negrín
  • GESMD – Grupo Español de Síndromes Mielodisplásicos
  • FICUS – Fundación de Investigación del Cáncer de la Universidad de Salamanca / CIC Salamanca
  • Registro Gammapatías Castilla y León